APA

Chittepu V. C. S. R., Kalhotra P., Osorio-Gallardo T., Gallardo-Velázquez T. & Osorio-Revilla G. (2019). Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study. : Pharmaceutics.

Chicago

Chittepu Veera C S R, Kalhotra Poonam, Osorio-Gallardo Tzayhri, Gallardo-Velázquez Tzayhri and Osorio-Revilla Guillermo. 2019. Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study. : Pharmaceutics.

Harvard

Chittepu V. C. S. R., Kalhotra P., Osorio-Gallardo T., Gallardo-Velázquez T. and Osorio-Revilla G. (2019). Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study. : Pharmaceutics.

MLA

Chittepu Veera C S R, Kalhotra Poonam, Osorio-Gallardo Tzayhri, Gallardo-Velázquez Tzayhri and Osorio-Revilla Guillermo. Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study. : Pharmaceutics. 2019.